Royalty Pharma to Present at Upcoming Investor Conferences

Rhea-AI Summary

Royalty Pharma (Nasdaq: RPRX) will present at two investor conferences in early December 2025: Citi 2025 Global Healthcare Conference on Tuesday, December 2 at 3:15 p.m. ET and Evercore 8th Annual Healthcare Conference on Wednesday, December 3 at 3:50 p.m. ET.

The company said webcasts of both presentations will be available on its Events page and archived for a minimum of 30 days, allowing investors to view the presentations after the live sessions.

NEW YORK, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in the following upcoming investor conferences during the month of December:

• Citi’s 2025 Global Healthcare Conference on Tuesday, December 2 at 3:15 p.m. ET
• Evercore’s 8^th Annual Healthcare Conference on Wednesday, December 3 at 3:50 p.m. ET

The webcast will be accessible from Royalty Pharma’s “Events” page at https://www.royaltypharma.com/investors/events/. The webcast will also be archived for a minimum of thirty days.

About Royalty Pharma

Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to leading global pharmaceutical companies. Royalty Pharma has assembled a portfolio of royalties which entitles it to payments based directly on the top-line sales of many of the industry’s leading therapies. Royalty Pharma funds innovation in the biopharmaceutical industry both directly and indirectly - directly when it partners with companies to co-fund late-stage clinical trials and new product launches in exchange for future royalties, and indirectly when it acquires existing royalties from the original innovators. Royalty Pharma’s current portfolio includes royalties on more than 35 commercial products, including Vertex’s Trikafta and Alyftrek, Johnson & Johnson’s Tremfya, GSK’s Trelegy, Roche’s Evrysdi, Servier’s Voranigo, Biogen’s Tysabri and Spinraza, AbbVie and Johnson & Johnson’s Imbruvica, Astellas and Pfizer’s Xtandi, Pfizer’s Nurtec ODT, and Gilead’s Trodelvy, among others, and 17 development-stage product candidates. For more information, visit www.royaltypharma.com.   

Royalty Pharma Investor Relations and Communications

+1 (212) 883-6637
ir@royaltypharma.com

FAQ

When will Royalty Pharma (RPRX) present at the Citi 2025 Global Healthcare Conference?

Royalty Pharma will present on Tuesday, December 2, 2025 at 3:15 p.m. ET.

What time is Royalty Pharma (RPRX) scheduled to speak at Evercore’s 8th Annual Healthcare Conference?

The presentation is scheduled for Wednesday, December 3, 2025 at 3:50 p.m. ET.

How can investors watch the Royalty Pharma (RPRX) conference webcasts?

Investors can watch live and archived webcasts via Royalty Pharma’s Events page at https://www.royaltypharma.com/investors/events/.

For how long will Royalty Pharma (RPRX) archive the conference webcasts?

The webcasts will be archived for a minimum of 30 days after the presentations.

Will Royalty Pharma (RPRX) provide slides or a replay for the December 2025 presentations?

The company said the presentations will be webcast and the webcasts will be archived, which typically allows replay access on the Events page.

Where can I find the schedule and links for Royalty Pharma’s (RPRX) December investor presentations?

Schedule details and webcast links are posted on Royalty Pharma’s Investors > Events page at the company website.